Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,192 | 5,535 | 9,663 | 4,499 | 5,798 |
| TOTAL | $14,202 | $5,942 | $10,360 | $5,114 | $6,120 |
| Non-Current Assets | |||||
| PPE Net | 3,432 | 420 | 3,249 | 591 | 678 |
| Intangibles | 3,490 | 238 | 0 | 253 | 261 |
| Other Non-Current Assets | 13,792 | 3,017 | 936 | 4,661 | 4,661 |
| TOTAL | $20,714 | $3,675 | $4,185 | $5,505 | $5,600 |
| Total Assets | $34,916 | $9,617 | $14,545 | $10,619 | $11,720 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,768 | 1,757 | 536 | 714 | 682 |
| Accrued Expenses | N/A | N/A | N/A | 1,751 | 1,367 |
| Other current liabilities | 769 | N/A | 1,305 | N/A | N/A |
| TOTAL | $5,634 | $3,591 | $2,032 | $2,465 | $2,049 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,575 | 246 | 4,819 | 154 | 185 |
| TOTAL | $6,652 | $1,065 | $4,819 | $1,301 | $1,332 |
| Total Liabilities | $12,286 | $4,656 | $6,851 | $3,766 | $3,381 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,959 | 2,390 | 2,306 | 2,306 | 1,176 |
| Common Shares | 99 | 328 | 51 | 165 | 165 |
| Retained earnings | -145,978 | -409,933 | -138,042 | -401,996 | -400,390 |
| TOTAL | $22,630 | $4,961 | $7,694 | $6,853 | $8,339 |
| Total Liabilities And Equity | $34,916 | $9,617 | $14,545 | $10,619 | $11,720 |